← Back to Search

Psychological Well-being Intervention for Healthcare Worker Burnout During COVID-19

N/A
Waitlist Available
Led By Charlesnika Evans, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up survey will be sent out at 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess the effectiveness of an online psychological well-being intervention (PARK) in reducing stress and associated-burnout, absenteeism, and intentions to leave the workforce in a subset of 750 persons who have been participating in a study of healthcare workers at Northwestern Medicine (NM) since Spring 2020.

Who is the study for?
This trial is for healthcare workers over 18 at Northwestern Medicine who are part of the NM HCW Serology Study and consent to participate. It includes pregnant women and all employees, except those no longer working at Northwestern Medicine.
What is being tested?
The PARK (Positive Affect Regulation sKills) online intervention is being tested to see if it can reduce stress, burnout, absenteeism, and intentions to leave among healthcare workers during the COVID-19 pandemic.
What are the potential side effects?
Since PARK is a psychological well-being intervention rather than a medical treatment, traditional side effects like with medication are not expected. However, participants may experience emotional discomfort or fatigue.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~survey will be sent out at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and survey will be sent out at 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Burnout
Burnout, Psychological
Psychological well-being
+1 more
Secondary study objectives
Cardiopulmonary Resuscitation
Cardiopulmonary Resuscitation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PARK NowExperimental Treatment1 Intervention
6-Week Self-Guided Program: PARK Positive Emotion Skills: The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access. A week will consist of 1-2 days of didactic material and 5-6 days of real-life skills practice and reporting. The maximum amount of time engaged in the PARK program for any participant is 5 hours over the 6-week period, plus completion of the REDCap surveys assessments (burnout, well-being, health behaviors). The intervention will focus on developing the following skills that will be supplemented by home practice: (1) positive events, capitalizing, gratitude; (2) mindfulness; (3) positive reappraisal; (4) personal strength and achievable goals; (5) and self-compassion. PARK is delivered through the BrightOutcome online platform.
Group II: Wait List Control-PARK LaterActive Control1 Intervention
Wait list controls will be assessed at similar time intervals and will be offered PARK at end of follow-up.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,039 Total Patients Enrolled
13 Trials studying COVID-19
71,457 Patients Enrolled for COVID-19
Charlesnika Evans, PhDPrincipal InvestigatorNorthwestern University

Media Library

Positive Affect Regulation Skills (PARK) Clinical Trial Eligibility Overview. Trial Name: NCT05394051 — N/A
COVID-19 Research Study Groups: PARK Now, Wait List Control-PARK Later
COVID-19 Clinical Trial 2023: Positive Affect Regulation Skills (PARK) Highlights & Side Effects. Trial Name: NCT05394051 — N/A
Positive Affect Regulation Skills (PARK) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05394051 — N/A
~142 spots leftby Nov 2025